Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:

Rx Wholesalers Must Provide “Value-Added Services” For HDMA Membership

  • News

Executive Summary

The Healthcare Distribution Management Association is requiring that drug wholesalers provide details of their value-added services as one of the criteria for active membership

You may also be interested in...



Wholesalers Drawing DoJ Scrutiny In Drug Diversion Investigations

Wholesalers will face increasing Justice Department scrutiny in pharmaceutical diversion cases, a federal prosecutor predicted

Wholesalers Drawing DoJ Scrutiny In Drug Diversion Investigations

Wholesalers will face increasing Justice Department scrutiny in pharmaceutical diversion cases, a federal prosecutor predicted

Rx Wholesalers Responding To Subpoenas On Deals With “Secondary” Market

AmerisourceBergen, Cardinal Health and McKesson are responding to subpoenas from the New York Attorney General's office regarding their use of "secondary" wholesalers as a source of pharmaceuticals

Table

View full table

Related Content

Pink Sheet
Pink Sheet
Pink Sheet
Pink Sheet
Pink Sheet
Pink Sheet
Tags:
Latest Headlines

‘Unbalanced’ EU HTA Timelines Exacerbated By Rare Disease & Cancer Drugs

National Drug Stockpiles Create ‘False Sense Of Security’

Patent Office Issues Proposed Rule For Rarely Successful Director Review Requests

Medicare Spending Forecast For Leqembi Reflects CMS Angst About Alzheimer’s Drug Costs

See All
UsernamePublicRestriction

Register

PS043410

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By